Aehr Test Systems (NASDAQ:AEHR) has been given an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.

Analysts have set a one year consensus price objective of $7.50 for the company, according to Zacks. Zacks has also given Aehr Test Systems an industry rank of 14 out of 255 based on the ratings given to its competitors.

Separately, TheStreet raised shares of Aehr Test Systems from a “d+” rating to a “c” rating in a research note on Friday, July 20th.

Shares of AEHR stock traded up $0.07 during mid-day trading on Monday, hitting $2.47. 49,000 shares of the stock were exchanged, compared to its average volume of 119,951. The company has a quick ratio of 3.20, a current ratio of 4.62 and a debt-to-equity ratio of 0.33. Aehr Test Systems has a 52-week low of $2.12 and a 52-week high of $4.10. The firm has a market cap of $51.37 million, a P/E ratio of 117.00 and a beta of 0.61.

Aehr Test Systems (NASDAQ:AEHR) last posted its earnings results on Thursday, July 19th. The semiconductor company reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. Aehr Test Systems had a net margin of 1.79% and a return on equity of 2.92%. The business had revenue of $7.27 million for the quarter.

In related news, CEO Gayn Erickson sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, July 24th. The shares were sold at an average price of $2.51, for a total value of $50,200.00. Following the transaction, the chief executive officer now directly owns 364,063 shares of the company’s stock, valued at approximately $913,798.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director John M. Schneider sold 14,168 shares of the firm’s stock in a transaction dated Thursday, August 2nd. The shares were sold at an average price of $2.40, for a total transaction of $34,003.20. Following the completion of the transaction, the director now directly owns 2,945 shares in the company, valued at $7,068. The disclosure for this sale can be found here. Over the last three months, insiders have sold 66,768 shares of company stock worth $167,965. Corporate insiders own 21.90% of the company’s stock.

A number of institutional investors have recently modified their holdings of the stock. Royce & Associates LP lifted its stake in Aehr Test Systems by 46.5% in the 2nd quarter. Royce & Associates LP now owns 446,800 shares of the semiconductor company’s stock valued at $1,050,000 after buying an additional 141,800 shares in the last quarter. B. Riley Financial Inc. lifted its stake in Aehr Test Systems by 520.0% in the 1st quarter. B. Riley Financial Inc. now owns 155,000 shares of the semiconductor company’s stock valued at $349,000 after buying an additional 130,000 shares in the last quarter. Renaissance Technologies LLC purchased a new position in Aehr Test Systems in the 4th quarter valued at about $405,000. Segall Bryant & Hamill LLC purchased a new position in Aehr Test Systems in the 1st quarter valued at about $322,000. Finally, Deutsche Bank AG purchased a new position in Aehr Test Systems in the 4th quarter valued at about $381,000. 22.49% of the stock is currently owned by hedge funds and other institutional investors.

Aehr Test Systems Company Profile

Aehr Test Systems designs, engineers, manufactures, and sells test and burn-in equipment used in the semiconductor industry worldwide. The company offers full wafer contact test systems, test during burn-in systems, test fixtures, die carriers, and related accessories; and Advanced Burn-in and Test System family of packaged part burn-in and test systems, which perform test during burn-in of complex devices, such as digital signal processors, microprocessors, microcontrollers, and systems-on-a-chip, as well as offer individual temperature control for high-power advanced logic devices.

Recommended Story: Marijuana Stocks Investing Considerations

Get a free copy of the Zacks research report on Aehr Test Systems (AEHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.